Tag: Agenus

Agenus and Gilead Close I-O Deal

Agenus Inc., an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, and adoptive cell therapies, today announced the closing of its immuno-oncology (I-O) partners...

Agenus to Leverage Selexis’ Modular SUREtechnology Platform

Selexis has expanded its alliance with clinical-stage immuno-oncology company Agenus by signing additional commercial license agreements (CLAs). Under the new CLAs, Agenus will leverage Selexis’ mo...